Full-Time
Global specialty chemicals for microbial control
$100k - $125k/yr
Morristown, NJ, USA
In Person
On-site in Morristown, New Jersey.
Master's, PhD
See people who can refer or advise you
Arxada provides specialty chemicals and microbial control solutions for industrial clients across industries such as wood protection, material protection, paints and coatings, hygiene, home and personal care, and crop protection. Its products are differentiated chemistries designed to protect materials, improve performance, and support sustainability, delivered through a regulatory-guided development process that includes IP work and R&D to register and bring solutions to market. The company differentiates itself through deep regulatory know-how, strong IP, and a proven development pipeline that accelerates bringing solutions to customers, and its merger with Troy expands its product portfolio and global reach. Its goal is to help industrial clients improve performance while advancing sustainability by providing reliable, compliant microbial control and specialty chemical solutions.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Basel, Switzerland
Founded
2015
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
Paid Vacation
Paid Sick Leave
Paid Holidays
Arxada has announced a long-term strategic agreement with Clorox Healthcare to launch Quanticare technology in North America. The collaboration debuts with Clorox Healthcare HyperOxi Disinfecting Wipes, featuring the EPA-registered sporicidal disinfectant. Quanticare is a bleach-free technology that kills C. difficile spores in four minutes and eliminates other pathogens, including C. auris and coronavirus, in one minute or less. The solution is designed for healthcare facilities to combat hospital-acquired infections, which cost the US healthcare system an estimated $28 billion annually. The non-bleach formulation is gentle on surfaces and suitable for frequent daily use. Arxada, headquartered in Basel, Switzerland, achieved sales of CHF 2 billion in 2024 and employs 3,200 associates across 24 production sites globally.
Arxada announces strategic agreement with Clorox Healthcare to launch Quanticare(TM) technology in Clorox Healthcare HyperOxi Disinfecting Wipes, a breakthrough sporicidal disinfectant for Healthcare facilities. Key Highlights * Revolutionary sporicidal technology: Kills C. difficile spores in 4 minutes1 and other pathogens, including C. auris and coronavirus, in 1 minute or less. * Strategic agreement with Clorox Healthcare: Long-term agreement to bring Quanticare(TM) hard-surface disinfectant technology to healthcare facilities across North America. * Non-bleach formula proven to reduce HAIs: EPA-registered solution designed specifically for front-line healthcare professionals managing hospital-acquired infections. MORRISTOWN, N.J., June 3, 2026 (Newswire.com) - Arxada, a global leader in specialty chemicals and innovative solutions, today announced a long-term strategic agreement with Clorox Healthcare to introduce its groundbreaking Quanticare(TM) hard-surface disinfectant technology to healthcare facilities across North America. The collaboration debuts with the launch of Clorox Healthcare HyperOxi Disinfecting Wipes with Quanticare(TM). This agreement marks a significant milestone in the rollout of Quanticare(TM) following its registration by the U.S. Environmental Protection Agency (EPA). Bleach-Free Disinfecting Technology Quanticare(TM) is a revolutionary, bleach-free sporicidal[1] technology that kills C. difficile spores in four minutes and eliminates other key pathogens-including Candidozyma auris (formerly Candida auris), M. tuberculosis, and norovirus-in one minute or less. Its non-bleach formulation is gentle on surfaces, supporting frequent daily use while helping healthcare facilities combat hospital-acquired infections (HAIs), which cost the U.S. healthcare system an estimated $28 billion annually.[2] "We're excited to enable Clorox Healthcare to bring this rapid and versatile disinfection solution to healthcare facilities," said Julie Gallucci, Global VP of Professional Hygiene at Arxada. "Clorox Healthcare is a trusted name for providing solutions to help stop the spread of infection in healthcare facilities and safeguard patients, and this collaboration enables us to accelerate the impact of Quanticare(TM) on healthcare disinfection on a large scale." Designed for Healthcare Professionals Quanticare(TM) was developed with front-line nurses, environmental services teams, and infection preventionists in mind-professionals on the front lines of preventing HAIs. These professionals need a reliable, ready-to-use daily disinfectant that delivers broad-spectrum efficacy, is gentle on surfaces, and is compatible with healthcare surfaces, enabling them to focus on what matters most: patient well-being. Industry Leadership and Expertise "Clorox has been helping healthcare facilities and professionals prevent the spread of HAIs for over a century, and we're proud to partner with Arxada to continue providing groundbreaking sporicidal disinfecting solutions to healthcare users. With the addition of Clorox Healthcare HyperOxi Disinfecting Wipes with Quanticare(TM), our product portfolio now includes a bleach-free alternative for eliminating C. difficile spores from healthcare environments," said Kyra Caskey, Senior Director of Marketing at The Clorox Company. Together, Arxada and Clorox Healthcare are demonstrating their shared commitment to reducing healthcare-associated infections with effective, broad-spectrum, ready-to-use disinfection solutions designed for real-world healthcare settings. * Data on file with Arxada; based on internally developed test methods. * Stone PW. Economic burden of healthcare-associated infections: An American perspective. Expert Review of Pharmacoeconomics & Outcomes Research. 2009;9(5):417-422. Media Contact Jane Smith Marketing Communications, Professional Hygiene Arxada [email protected] About Arxada Arxada is a global leader in innovative solutions that protect our world. Our groundbreaking technologies, in-depth regulatory know-how, manufacturing and process development help our customers to safeguard nutrition, health and infrastructure efficiently through chemistry and biotechnology that enhance sustainability. We offer a broad portfolio of ingredients and services for multiple end-markets that include Human Health & Nutrition, Home & Personal Care, Professional Hygiene, Paints & Coatings and Wood Protection. With customers in more than 100 countries, the company achieved sales of CHF 2 billion in 2024. Headquartered in Basel (Switzerland), Arxada employs 3,200 associates across 24 production sites and 14 R&D centers, all committed to our customers' success. To learn more about Arxada, visit our website arxada.com and Arxada on LinkedIn. About Clorox Healthcare Building on a century-long legacy in cleaning and disinfecting, Clorox Healthcare continues to advance infection prevention by offering a wide range of innovative products to help stop the spread of infection in healthcare facilities. Clorox Healthcare is committed to delivering trusted solutions that support the evolving needs of the healthcare community. For more information, visit www.CloroxHealthcare.com and follow CloroxPro on LinkedIn. Use biocides safely. Always read the label and product information before use. All product information corresponds to Arxada's knowledge on the subject at the date of publication, but Arxada makes no warranty as to its accuracy or completeness, and Arxada assumes no obligation to update it. Product information is intended for use by recipients experienced and knowledgeable in the field, who are capable of and responsible for independently determining the suitability of ingredients for intended uses and to ensure their compliance with applicable law. All trademarks belong to Arxada, LLC or its affiliates. (C) 2026 Arxada.
VP, Assistant General Counsel with CorMedix placed by Princeton Legal Search Group, LLC. By: Princeton Legal Search Group, LLC April 13, 2026 Kate Perez Whittaker is VP, Assistant General Counsel with CorMedix. CorMedix is a publicly traded biopharmaceutical company focused on developing and commercializing innovative products that help prevent life-threatening infections and improve outcomes for patients with chronic kidney disease and other serious conditions. Kate has wide range responsibilities and provides guidance and counsel on alliance management, mergers and acquisitions, corporate governance, commercial contracts, regulatory matters, employment, litigation oversight and intellectual property. Kate joined CorMedix from Arxada where she was Head of Legal - North America.
Geogard NEU(R): affordable, sustainable next-gen product protection at neutral pH. Arxada's breakthrough in multifunctional product protection technology for cosmetics and personal care. April 8, 2026 Last month, Arxada launched Geogard(R) NEU, a breakthrough multifunctional product protection technology for cosmetics and personal care. This water-soluble, easy-to-formulate system delivers affordable product protection at low use levels (starting at 0.03%) for both rinse-off and leave-on formats. Designed to meet sustainability and conscious beauty trends, Geogard(R) NEU combines well-known multifunctional ingredients in a patented synergistic blend, offering surprising antimicrobial efficacy - even at neutral pH where traditional organic acids fail. It addresses formulators' challenges of cost, compliance, and versatility, outperforming conventional preservative systems under regulatory scrutiny. According to Arxada, Geogard(R) NEU is a game-changer for brands seeking safe, effective and consumer-friendly protection without compromising quality or budget. Happi caught up with Dr. Sabrina Behnke, global director for marketing and growth, personal care at Arxada, to learn more about Geogard(R) NEU. Happi: what are Geogard NEU's benefits for formulators and how is this product distinct in terms of formulation flexibility and performance? Behnke: The Geogard(R) NEU multifunctional system brings a fresh approach to multifunctional product protection compared with what formulators typically rely on today. Most multifunctional ingredients used for product protection, such as caprylyl glycol or ethylhexylglycerin, need to be added at around 0.3-1.0%, and those higher levels can start to influence the overall formulation properties including viscosity, texture or flow. With the Geogard(R) NEU multifunctional system, we're introducing a technology that performs effectively at inclusion levels 10-30 times lower, which means those unwanted formulation changes are far less likely while still delivering strong protection. It's also fully water-soluble, easy to handle, and flexible enough to be added at virtually any point in the formulation process. Happi: what applications are best for Geogard NEU and why? Behnke: The Geogard(R) NEU multifunctional system presents a true alternative for cost-sensitive applications that previously had a limited palette of product protection ingredients to choose from. It's versatile not only across many rinse-off formats but is also equally suitable for leave-on formulations like lotions and creams. With an excellent safety profile and global regulatory compliance, the Geogard(R) NEU multifunctional system gives the industry a tool that can be adopted into new (and existing) formulations with speed. Simultaneously, the Geogard(R) NEU system delivers multifunctional benefits such as chelation, antioxidant power, and skin conditioning benefits which are ideal for formulators trying to achieve additional formulation benefits with fewer ingredients. Due to its low inclusion levels, the Geogard(R) NEU multifunctional system is a great candidate for cost-sensitive formulations for shower gels, shampoos and liquid soaps and other systems that work well within a neutral pH range (up to pH 7). These systems have traditionally relied on the combination of Methylisothiazolinone and Methylchloroisothiazolinone, more recently almost exclusively on combinations of Phenoxyethanol and Sodium Benzoate. Regulatory limits of MIT/CMIT have been lowered, and the preservatives are now under heightened consumer scrutiny. While Phenoxyethanol is safe to use at concentrations up to 1%, more brands are formulating away from it, because of this heightened scrutiny. Happi: how does Geogard NEU help brands meet sustainability goals? Behnke: Arxada's sustainability priorities are reflected in the development of the Geogard(R) NEU multifunctional system, which was designed to deliver strong product protection with a lighter environmental footprint. The technology features a 51% renewable carbon index and works at use levels 10 to 30 times lower than many conventional preservation systems, allowing formulators to reduce material consumption without compromising efficacy. Its natural origin content, calculated according to ISO 16128, is 42%, giving brands a transparent benchmark for meeting today's expectations around more sustainable, nature-aligned formulations. The Geogard(R) NEU multifunctional system also incorporates hydroxyacetophenone, a nature-identical component as well as copper gluconate which is produced using fermentation-based gluconic acid. Complementing the ingredient design, Arxada continues to strengthen its sustainability foundations by partnering with raw material suppliers who share its commitments to responsible sourcing and reducing carbon emissions across the value chain. These efforts support Arxada's broader mission to safeguard human health, reduce waste, conserve resources, and extend product lifecycles through thoughtful preservation. Looking ahead to 2030, Arxada is expanding product-level carbon tracking, advancing science-based advocacy, and working toward ensuring that 100% of key suppliers complete comprehensive ESG assessments, all of which support long-term commitment to delivering preservation technologies that are not only high performing, but meaningfully more sustainable. Happi: what consumer demands are shaping how Arxada develops ingredients? Behnke: The personal care preservative and multifunctional landscape is constantly changing and evolving, driven by regulations and trends such as "clean beauty" In response, Arxada focuses on creating safe, simple, and more sustainable solutions that align with customer expectations from modern ingredients. We also carefully analyze gaps in today's preservative and multifunctional offerings, especially the pain points formulators encounter, and design technologies that directly address those unmet needs. This approach ensures we deliver ingredients that not only meet evolving consumer demands but are also a joy to formulate. Happi: how can formulators get more information about Geogard(R) NEU? Behnke: For formulators attending NYSCC Supplier's Day in New York City, we invite you to visit our booth to engage directly with our technical and marketing experts and explores the benefits of the Geogard(R) NEU system firsthand. We also encourage you to reach out to your local Arxada sales representative, who will be pleased to provide an early introduction to this innovation. Review and follow all product safety instructions, available at www.arxada.com. (C) 2026 Arxada Request more information from Arxada.
Arxada, a global leader in specialty chemicals and innovative solutions, announced the launch of Polyboost(TM), a unique multifunctional additive developed to enhance a wide range of paint and coating properties.